1 - 9 out of 9Page size: 10
  1. 2023

  2. Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer

    Dings, M. P. G., Manoukian, P., Waasdorp, C., Quik, J. S. E., Strijker, M., Lodestijn, S. C., van Neerven, S. M., Moreno, L. F., de Oliveira, R. L., Bonsing, B. A., Bruno, M. J., Busch, O. R., Doukas, M., van Eijck, C. H., Mohammad, N. H., de Hingh, I. H., Molenaar, Q. I., Besselink, M. G., Vermeulen, L., Medema, J. P., & 2 othersvan Laarhoven, H. W. M. & Bijlsma, M. F., 1 Feb 2023, In: International Journal of Cancer. 152, 3, p. 511-523 13 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. 2022

  4. Molecular characterization of colorectal cancer related peritoneal metastatic disease

    Lenos, K. J., Bach, S., Ferreira Moreno, L., ten Hoorn, S., Sluiter, N. R., Bootsma, S., Vieira Braga, F. A., Nijman, L. E., van den Bosch, T., Miedema, D. M., van Dijk, E., Ylstra, B., Kulicke, R., Davis, F. P., Stransky, N., Smolen, G. A., Coebergh van den Braak, R. R. J., IJzermans, J. N. M., Martens, J. W. M., Hallam, S., & 20 othersBeggs, A. D., Kops, G. J. P. L., Lansu, N., Bastiaenen, V. P., Klaver, C. E. L., Lecca, M. C., el Makrini, K., Elbers, C. C., Dings, M. P. G., van Noesel, C. J. M., Kranenburg, O., Medema, J. P., Koster, J., Koens, L., Punt, C. J. A., Tanis, P. J., de Hingh, I. H., Bijlsma, M. F., Tuynman, J. B. & Vermeulen, L., 1 Dec 2022, In: Nature communications. 13, 1, 4443.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Estrogen-related receptor alpha drives mitochondrial biogenesis and resistance to neoadjuvant chemoradiation in esophageal cancer

    Dings, M. P. G., van der Zalm, A. P., Bootsma, S., van Maanen, T. F. J., Waasdorp, C., van den Ende, T., Liu, D., Bailey, P., Koster, J., Zwijnenburg, D. A., Spek, C. A., Klomp, J. P. G., Oubrie, A., Hooijer, G. K. J., Meijer, S. L., van Berge Henegouwen, M. I., Hulshof, M. C., Bergman, J., Oyarce, C., Medema, J. P., & 2 othersvan Laarhoven, H. W. M. & Bijlsma, M. F., 15 Nov 2022, In: Cell Reports Medicine. 3, 11, 100802.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. Impact of classical and basal-like molecular subtypes on overall survival in resected pancreatic cancer in the SPACIOUS-2 multicentre study

    Dutch Pancreatic Cancer Group, 14 Oct 2022, In: The British journal of surgery. 109, 11, p. 1150-1155 6 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  7. 2021

  8. Neoadjuvant chemoradiotherapy combined with atezolizumab for resectable esophageal adenocarcinoma: A single-arm phase ii feasibility trial (PERFECT)

    Van Den Ende, T., De Clercq, N. C., Van Berge Henegouwen, M. I., Gisbertz, S. S., Geijsen, E. D., Verhoeven, R. H. A., Meijer, S. L., Schokker, S., Dings, M. P. G., Bergman, J. J. G. H. M., Mohammad, N. H., Ruurda, J. P., Van Hillegersberg, R., Mook, S., Nieuwdorp, M., De Gruijl, T. D., Soeratram, T. T. D., Ylstra, B., Van Grieken, N. C. T., Bijlsma, M. F., & 2 othersHulshof, M. C. C. M. & Van Laarhoven, H. W. M., Jun 2021, In: Clinical cancer research. 27, 12, p. 3351-3359 9 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  9. Systems biology and molecular characterization of subtypes to guide targeted therapies in gastric cancer

    Dings, M. P. G., Vermeulen, L. & Bijlsma, M. F., 1 Jan 2021, Research and Clinical Applications of Targeting Gastric Neoplasms. Elsevier, p. 259-288 (Research and Clinical Applications of Targeting Gastric Neoplasms).

    Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review

  10. Systems biology and molecular characterization of subtypes to guide targeted therapies in gastric cancer

    Dings, M. P. G., Vermeulen, L. & Bijlsma, M. F., 2021, Research and Clinical Applications of Targeting Gastric Neoplasms. p. 259-288

    Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic

  11. 2020

  12. Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classification systems

    Dijk, F., Veenstra, V. L., Soer, E. C., Dings, M. P. G., Zhao, L., Halfwerk, J. B., Hooijer, G. K., Damhofer, H., Marzano, M., Steins, A., Waasdorp, C., Busch, O. R., Besselink, M. G., Tol, J. A., Welling, L., van Rijssen, L. B., Klompmaker, S., Wilmink, H. W., van Laarhoven, H. W., Medema, J. P., & 7 othersVermeulen, L., van Hooff, S. R., Koster, J., Verheij, J., van de Vijver, M. J., Wang, X. & Bijlsma, M. F., 1 Dec 2020, In: Scientific reports. 10, 1, p. 337 337.

    Research output: Contribution to journal › Article › Academic › peer-review

  13. Ccaat/enhancer-binding protein delta (C/ebpδ): A previously unrecognized tumor suppressor that limits the oncogenic potential of pancreatic ductal adenocarcinoma cells

    Hartl, L., Duitman, J., Aberson, H. L., Chen, K., Dijk, F., Roelofs, J. J. T. H., Dings, M. P. G., Hooijer, G. K. J., Hernanda, P. Y., Pan, Q., Busch, O. R., Besselink, M. G. H., Boerman, T., Peppelenbosch, M. P., Bijlsma, M. F. & Spek, C. A., 1 Sep 2020, In: Cancers. 12, 9, p. 1-21 21 p., 2546.

    Research output: Contribution to journal › Article › Academic › peer-review

ID: 5199603